Stephen Alistair Logarnini

Title: The Innovations of Stephen Alistair Logarnini

Introduction

Stephen Alistair Logarnini is a notable inventor based in East St. Kilda, Australia. He has made significant contributions to the field of medical research, particularly in the area of infectious diseases. His work focuses on the Hepatitis E Virus, which poses a considerable health risk globally.

Latest Patents

Logarnini holds a patent for "Immunoreactive antigens of Hepatitis E Virus." This invention relates to molecules such as peptides, polypeptides, and proteins that carry epitopes, specifically B cell epitopes from antigenic proteins encoded by the Hepatitis E Virus. These molecules are selectively immunoreactive to convalescent and/or acute phase circulating antibodies to the Hepatitis E Virus. They are useful in the development of diagnostic, therapeutic, and prophylactic agents for Hepatitis E Virus.

Career Highlights

Logarnini is associated with the Macfarlane Burnet Centre for Medical Research Limited, where he contributes to groundbreaking research in immunology and virology. His work has implications for improving diagnostic methods and treatment options for Hepatitis E Virus.

Collaborations

Some of his notable coworkers include Fan Li and Zhuang Hui, who collaborate with him on various research projects aimed at advancing medical science.

Conclusion

Stephen Alistair Logarnini's innovative work in the field of medical research highlights the importance of developing effective solutions for infectious diseases. His contributions are paving the way for advancements in diagnostics and therapeutics for Hepatitis E Virus.